271 related articles for article (PubMed ID: 28783169)
1. Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.
Guerrero PA; Tchaicha JH; Chen Z; Morales JE; McCarty N; Wang Q; Sulman EP; Fuller G; Lang FF; Rao G; McCarty JH
Oncogene; 2017 Nov; 36(47):6568-6580. PubMed ID: 28783169
[TBL] [Abstract][Full Text] [Related]
2. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
3. αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.
Reyes SB; Narayanan AS; Lee HS; Tchaicha JH; Aldape KD; Lang FF; Tolias KF; McCarty JH
Mol Biol Cell; 2013 Feb; 24(4):474-82. PubMed ID: 23283986
[TBL] [Abstract][Full Text] [Related]
4. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.
Wu Q; Berglund AE; MacAulay RJ; Etame AB
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008722
[TBL] [Abstract][Full Text] [Related]
5. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
Vora P; Seyfrid M; Venugopal C; Qazi MA; Salim S; Isserlin R; Subapanditha M; O'Farrell E; Mahendram S; Singh M; Bakhshinyan D; Chokshi C; McFarlane N; Dvorkin-Gheva A; Brown KR; Murty N; Moffat J; Bader GD; Singh SK
J Neurooncol; 2019 Jul; 143(3):417-428. PubMed ID: 31115870
[TBL] [Abstract][Full Text] [Related]
6. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.
Mao DD; Gujar AD; Mahlokozera T; Chen I; Pan Y; Luo J; Brost T; Thompson EA; Turski A; Leuthardt EC; Dunn GP; Chicoine MR; Rich KM; Dowling JL; Zipfel GJ; Dacey RG; Achilefu S; Tran DD; Yano H; Kim AH
Cell Rep; 2015 Jun; 11(11):1809-21. PubMed ID: 26074073
[TBL] [Abstract][Full Text] [Related]
7. PNIPAAm-co-Jeffamine
Heffernan JM; McNamara JB; Borwege S; Vernon BL; Sanai N; Mehta S; Sirianni RW
Biomaterials; 2017 Oct; 143():149-158. PubMed ID: 28802102
[TBL] [Abstract][Full Text] [Related]
8. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
9. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
10. m
Cui Q; Shi H; Ye P; Li L; Qu Q; Sun G; Sun G; Lu Z; Huang Y; Yang CG; Riggs AD; He C; Shi Y
Cell Rep; 2017 Mar; 18(11):2622-2634. PubMed ID: 28297667
[TBL] [Abstract][Full Text] [Related]
11. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.
Tchaicha JH; Reyes SB; Shin J; Hossain MG; Lang FF; McCarty JH
Cancer Res; 2011 Oct; 71(20):6371-81. PubMed ID: 21859829
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
[TBL] [Abstract][Full Text] [Related]
14. Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.
Esaki S; Nigim F; Moon E; Luk S; Kiyokawa J; Curry W; Cahill DP; Chi AS; Iafrate AJ; Martuza RL; Rabkin SD; Wakimoto H
Int J Cancer; 2017 Dec; 141(11):2348-2358. PubMed ID: 28801914
[TBL] [Abstract][Full Text] [Related]
15. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
16. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo.
Chiao MT; Yang YC; Cheng WY; Shen CC; Ko JL
Curr Neurovasc Res; 2011 Aug; 8(3):210-9. PubMed ID: 21675958
[TBL] [Abstract][Full Text] [Related]
17. SH3BGRL2 functions as a crucial tumor suppressor in glioblastoma tumorigenesis.
Nie Z; Cai S; Wei Z; Li Y; Bian L; Wang C; Wang C
Biochem Biophys Res Commun; 2021 Apr; 547():148-154. PubMed ID: 33610914
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic activity of SOX1 in glioblastoma.
Garcia I; Aldaregia J; Marjanovic Vicentic J; Aldaz P; Moreno-Cugnon L; Torres-Bayona S; Carrasco-Garcia E; Garros-Regulez L; Egaña L; Rubio A; Pollard S; Stevanovic M; Sampron N; Matheu A
Sci Rep; 2017 Apr; 7():46575. PubMed ID: 28425506
[TBL] [Abstract][Full Text] [Related]
19. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
20. Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells.
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Neuropathology; 2014 Aug; 34(4):378-85. PubMed ID: 24673436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
